Cargando…
Virtual screening following rational drug design based approach for introducing new anti amyloid beta aggregation agent
Amyloid β (Aβ) sheets aggregations is the main reason of Alzheimer disease. The interacting areas between monomers are residue number 38 to 42. Inhibition of interaction between Aβ molecules prevents plaque formation. In the present study, we have performed a high-throughput virtual screening among...
Autores principales: | Rigi, Garshasb, Nakhaei, Mohammad Vala Ashdar, Eidipour, Hoda, Najimi, Arshia, Tajik, Fahimeh, Taher, Niloufar, Yarahmadi, Kamran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463618/ https://www.ncbi.nlm.nih.gov/pubmed/28642635 http://dx.doi.org/10.6026/97320630013042 |
Ejemplares similares
-
Molecular docking based screening of Listeriolysin-O for improved inhibitors
por: Ghafari, Sara, et al.
Publicado: (2017) -
Molecular docking based virtual screening of compounds for inhibiting sortase A in L.monocytogenes
por: Rashidieh, Behnam, et al.
Publicado: (2015) -
Molecular docking based screening of predicted potential inhibitors for VP40 from Ebola virus
por: Abazari, Danya, et al.
Publicado: (2015) -
Shear-Induced Amyloid Aggregation in the Brain: V. Are Alzheimer’s and Other Amyloid Diseases Initiated in the Lower Brain and Brainstem by Cerebrospinal Fluid Flow Stresses?
por: Trumbore, Conrad N.
Publicado: (2021) -
Competitive rational inhibitor design to 4-maleylaceto-acetate isomerase
por: Zolfaghari, Narges
Publicado: (2017)